HomeClinical TopicsFDA allows marketing of cooling cap for chemotherapy

FDA allows marketing of cooling cap for chemotherapy

On Dec. 8, the U.S. Food and Drug Administration (FDA) cleared the Dignitana DigniCap Cooling System for marketing. The system reduces the frequency and severity of alopecia during chemotherapy in breast cancer patients. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

NP taking pregnant woman's blood pressure

AHA: It’s Safe to Treat High Blood Pressure During Pregnancy

High blood pressure during pregnancy can present significant risks to mother and child, but practitioners have sometimes be hesitant to prescribe blood pressure medication...